Overview

Aspirin Resistance and Stroke Risk: Platelet Function Analysis in Patients With Ischemic Events

Status:
Completed
Trial end date:
2011-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine if PFA results correlate with ischemic event outcomes as well as bleeding complications. Hypothesis is antiplatelet agents will be more efficacious if they are administered in a dose-adjusted manner using PFA results as a guide.
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
Northwestern University
Treatments:
Aspirin
Clopidogrel
Ticlopidine